Mepolizumab para el tratamiento de asma grave eosinofílica. Rev Alerg Mex [Internet]. 2020 Dec. 18 [cited 2025 May 2];67(7). Available from: https://www.revistaalergia.mx/ojs/index.php/ram/article/view/780